Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
boston blog main
life sciences
national blog main
national top stories
new york blog main
sanofi
3
×
biotech
boston top stories
clinical trials
deals
fda
national
new york top stories
novartis
rna interference
san francisco blog main
startups
venture capital
abbvie
akouos
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
amy schulman
andreas klein
anirvan ghosh
anna greka
astrazeneca
barry greene
biogen
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
car-t
What
medicines
3
×
deal
acquire
acquisitions
agreed
announced
aren’t
billion
bio
brings
car
cash
ceo
cholesterol
collabs
company
compound
covid
cutting
daniel
drug
edge
experiments
fda
gene
gilead
gilead’s
help
hot
interference
introduce
ipo
launch
market
medco
month
new
novartis
o’day
payers
Language
unset
Current search:
sanofi
×
medicines
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
